Octopus Biosafety (STU:OCR) Research & Development: €0.00 Mil (TTM As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
11 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety Research & Development?

Octopus Biosafety STU:OCR 11 Research & Development is €0.00 Mil as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 11/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Octopus Biosafety's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Octopus Biosafety  (STU:OCR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Octopus Biosafety Research & Development Related Terms

Octopus Biosafety Research & Development Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety Research & Development Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:OCR
11GF Score
Octopus Biosafety STU:OCR
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Octopus Biosafety (STU:OCR) has a Research & Development of €0.00 Mil as of Dec. 2024. Research and development expense is the total cost for research and development activities. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Research & Development too high?
Octopus Biosafety's current Research & Development is €0.00 Mil. Overall, Octopus Biosafety has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Research & Development compare to DELL and SNDK?
Octopus Biosafety's Research & Development of €0.00 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Research & Development is €0.00 Mil. Octopus Biosafety's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Research & Development is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 11/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
11GF Score

Get the complete analysis for STU:OCR

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value